Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Medical, Undergraduate | 4 | 2016 | 84 | 1.540 |
Why?
|
| Geriatrics | 4 | 2017 | 94 | 1.480 |
Why?
|
| Accidental Falls | 5 | 2016 | 207 | 1.460 |
Why?
|
| Models, Educational | 2 | 2014 | 18 | 0.950 |
Why?
|
| Gait | 4 | 2014 | 115 | 0.910 |
Why?
|
| Risk Assessment | 5 | 2017 | 1312 | 0.900 |
Why?
|
| Clinical Competence | 6 | 2018 | 307 | 0.870 |
Why?
|
| Internal Medicine | 2 | 2019 | 45 | 0.820 |
Why?
|
| Curriculum | 4 | 2019 | 196 | 0.820 |
Why?
|
| Patient Readmission | 2 | 2019 | 105 | 0.790 |
Why?
|
| Faculty, Medical | 2 | 2019 | 69 | 0.770 |
Why?
|
| Staff Development | 1 | 2019 | 13 | 0.720 |
Why?
|
| Teaching | 2 | 2019 | 55 | 0.720 |
Why?
|
| Cognition | 5 | 2013 | 526 | 0.710 |
Why?
|
| Holidays | 1 | 2019 | 3 | 0.700 |
Why?
|
| Continuity of Patient Care | 2 | 2019 | 64 | 0.690 |
Why?
|
| Education, Medical | 1 | 2019 | 67 | 0.690 |
Why?
|
| Students, Medical | 3 | 2016 | 121 | 0.670 |
Why?
|
| Teaching Rounds | 1 | 2018 | 5 | 0.650 |
Why?
|
| Geriatric Assessment | 5 | 2014 | 356 | 0.630 |
Why?
|
| Physical Examination | 1 | 2018 | 82 | 0.620 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 68 | 0.610 |
Why?
|
| Aging | 6 | 2014 | 881 | 0.600 |
Why?
|
| Internship and Residency | 3 | 2017 | 283 | 0.590 |
Why?
|
| Motor Activity | 3 | 2009 | 311 | 0.570 |
Why?
|
| Aged | 28 | 2019 | 9510 | 0.550 |
Why?
|
| Food Services | 1 | 2014 | 18 | 0.500 |
Why?
|
| Health Personnel | 1 | 2014 | 111 | 0.440 |
Why?
|
| Walking | 4 | 2007 | 178 | 0.420 |
Why?
|
| Cognition Disorders | 4 | 2013 | 390 | 0.410 |
Why?
|
| Depression | 4 | 2014 | 383 | 0.410 |
Why?
|
| Humans | 33 | 2019 | 29213 | 0.400 |
Why?
|
| Educational Measurement | 3 | 2016 | 111 | 0.360 |
Why?
|
| Female | 26 | 2019 | 18236 | 0.330 |
Why?
|
| Women's Health | 1 | 2009 | 226 | 0.310 |
Why?
|
| Body Composition | 2 | 2007 | 365 | 0.280 |
Why?
|
| Male | 23 | 2019 | 17872 | 0.280 |
Why?
|
| Health Status | 2 | 2007 | 369 | 0.270 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 150 | 0.250 |
Why?
|
| Risk Factors | 12 | 2019 | 3547 | 0.250 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 4 | 2009 | 134 | 0.240 |
Why?
|
| North Carolina | 3 | 2019 | 1424 | 0.230 |
Why?
|
| Fractures, Bone | 2 | 2014 | 150 | 0.200 |
Why?
|
| Time Factors | 2 | 2019 | 2003 | 0.180 |
Why?
|
| Video Recording | 1 | 2019 | 52 | 0.180 |
Why?
|
| Attitude of Health Personnel | 2 | 2018 | 163 | 0.180 |
Why?
|
| Program Development | 1 | 2019 | 85 | 0.170 |
Why?
|
| Hip Fractures | 1 | 2017 | 30 | 0.150 |
Why?
|
| Nutritional Status | 1 | 2017 | 68 | 0.150 |
Why?
|
| Patient Care Team | 1 | 2018 | 124 | 0.150 |
Why?
|
| Follow-Up Studies | 4 | 2014 | 2114 | 0.150 |
Why?
|
| Communication | 1 | 2018 | 122 | 0.150 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 3726 | 0.140 |
Why?
|
| Adult | 3 | 2019 | 8466 | 0.140 |
Why?
|
| Prospective Studies | 6 | 2016 | 2027 | 0.140 |
Why?
|
| Education | 1 | 2016 | 30 | 0.140 |
Why?
|
| Double-Blind Method | 4 | 2009 | 504 | 0.130 |
Why?
|
| Comorbidity | 4 | 2017 | 546 | 0.130 |
Why?
|
| Program Evaluation | 1 | 2016 | 175 | 0.130 |
Why?
|
| Telemedicine | 1 | 2016 | 77 | 0.130 |
Why?
|
| Hypertension | 2 | 2014 | 912 | 0.130 |
Why?
|
| Hemoglobins | 2 | 2005 | 42 | 0.130 |
Why?
|
| Middle Aged | 8 | 2019 | 10868 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2014 | 1382 | 0.120 |
Why?
|
| United States | 4 | 2017 | 3648 | 0.120 |
Why?
|
| Tamoxifen | 1 | 2013 | 48 | 0.120 |
Why?
|
| Vitamin D | 1 | 2014 | 173 | 0.110 |
Why?
|
| Cardiovascular Diseases | 3 | 2012 | 1017 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2013 | 454 | 0.110 |
Why?
|
| Medication Adherence | 1 | 2013 | 144 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 343 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 177 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2010 | 25 | 0.100 |
Why?
|
| Arteries | 1 | 2010 | 60 | 0.090 |
Why?
|
| Muscle, Skeletal | 2 | 2005 | 494 | 0.090 |
Why?
|
| Retrospective Studies | 2 | 2016 | 3121 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2012 | 467 | 0.090 |
Why?
|
| Dementia | 2 | 2009 | 234 | 0.090 |
Why?
|
| Fosinopril | 1 | 2009 | 3 | 0.090 |
Why?
|
| Fibrinolysis | 1 | 2009 | 7 | 0.090 |
Why?
|
| Cystatins | 1 | 2008 | 8 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2007 | 67 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 667 | 0.080 |
Why?
|
| Logistic Models | 3 | 2017 | 729 | 0.080 |
Why?
|
| Weight Lifting | 1 | 2006 | 9 | 0.070 |
Why?
|
| Exercise Test | 1 | 2007 | 194 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2007 | 137 | 0.070 |
Why?
|
| Osteoarthritis, Knee | 1 | 2006 | 80 | 0.070 |
Why?
|
| Intelligence Tests | 1 | 2005 | 9 | 0.070 |
Why?
|
| Smoking | 2 | 2008 | 439 | 0.070 |
Why?
|
| Incidence | 3 | 2014 | 1123 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2008 | 239 | 0.070 |
Why?
|
| Social Class | 1 | 2005 | 78 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2007 | 1694 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2008 | 312 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2006 | 229 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2005 | 240 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2007 | 360 | 0.060 |
Why?
|
| Italy | 4 | 2004 | 15 | 0.060 |
Why?
|
| Prognosis | 1 | 2007 | 1363 | 0.060 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2003 | 5 | 0.060 |
Why?
|
| Pennsylvania | 2 | 2014 | 77 | 0.060 |
Why?
|
| Antioxidants | 1 | 2004 | 114 | 0.060 |
Why?
|
| Tennessee | 2 | 2014 | 97 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2004 | 211 | 0.060 |
Why?
|
| Inpatients | 1 | 2003 | 64 | 0.050 |
Why?
|
| Inflammation | 1 | 2005 | 508 | 0.050 |
Why?
|
| Quality of Life | 1 | 2007 | 819 | 0.050 |
Why?
|
| Diet | 1 | 2004 | 356 | 0.050 |
Why?
|
| Brain | 1 | 2008 | 930 | 0.050 |
Why?
|
| Alcohol Drinking | 1 | 2002 | 246 | 0.040 |
Why?
|
| Hospitalization | 1 | 2002 | 417 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2008 | 867 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2014 | 807 | 0.040 |
Why?
|
| Obesity | 1 | 2005 | 1068 | 0.040 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2017 | 13 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2017 | 91 | 0.040 |
Why?
|
| ROC Curve | 1 | 2017 | 149 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2009 | 95 | 0.040 |
Why?
|
| Absenteeism | 1 | 2016 | 11 | 0.040 |
Why?
|
| Observation | 1 | 2016 | 24 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 724 | 0.040 |
Why?
|
| Peer Group | 1 | 2016 | 41 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2017 | 370 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 92 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2017 | 181 | 0.030 |
Why?
|
| Physicians | 1 | 2017 | 135 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2008 | 186 | 0.030 |
Why?
|
| Age Distribution | 2 | 2008 | 198 | 0.030 |
Why?
|
| Prevalence | 1 | 2017 | 907 | 0.030 |
Why?
|
| Drug Utilization | 1 | 2014 | 47 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 70 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2013 | 24 | 0.030 |
Why?
|
| African Continental Ancestry Group | 1 | 2014 | 350 | 0.030 |
Why?
|
| Risk | 1 | 2013 | 290 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 709 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2013 | 379 | 0.030 |
Why?
|
| Postmenopause | 1 | 2013 | 397 | 0.030 |
Why?
|
| Bone Density | 1 | 2012 | 183 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 2010 | 25 | 0.020 |
Why?
|
| Elasticity | 1 | 2010 | 34 | 0.020 |
Why?
|
| Efficiency | 1 | 2010 | 16 | 0.020 |
Why?
|
| Research | 1 | 2010 | 72 | 0.020 |
Why?
|
| Publishing | 1 | 2010 | 57 | 0.020 |
Why?
|
| European Continental Ancestry Group | 1 | 2014 | 1131 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2413 | 0.020 |
Why?
|
| Motivation | 1 | 2010 | 104 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2009 | 42 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2009 | 17 | 0.020 |
Why?
|
| Cystatin C | 1 | 2008 | 28 | 0.020 |
Why?
|
| Ginkgo biloba | 1 | 2007 | 19 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2008 | 61 | 0.020 |
Why?
|
| Educational Status | 1 | 2008 | 165 | 0.020 |
Why?
|
| Health Surveys | 1 | 2008 | 191 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2007 | 23 | 0.020 |
Why?
|
| Canada | 1 | 2007 | 49 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2008 | 221 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 160 | 0.020 |
Why?
|
| Arthralgia | 1 | 2006 | 31 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 572 | 0.020 |
Why?
|
| Physical Fitness | 1 | 2006 | 120 | 0.020 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2005 | 46 | 0.020 |
Why?
|
| Knee Joint | 1 | 2006 | 129 | 0.020 |
Why?
|
| Research Design | 1 | 2007 | 286 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 466 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2005 | 225 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 232 | 0.020 |
Why?
|
| Anemia | 1 | 2004 | 55 | 0.010 |
Why?
|
| Vitamins | 1 | 2004 | 59 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1365 | 0.010 |
Why?
|
| Digoxin | 1 | 2003 | 3 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 2003 | 9 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 2003 | 13 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 110 | 0.010 |
Why?
|
| Diuretics | 1 | 2003 | 22 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2003 | 93 | 0.010 |
Why?
|
| Pharmacoepidemiology | 1 | 2002 | 2 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 71 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2002 | 80 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 726 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 788 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2003 | 122 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2003 | 448 | 0.010 |
Why?
|
| Exercise | 1 | 2006 | 595 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 333 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 285 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 864 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 871 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2006 | 3108 | 0.010 |
Why?
|